YieldMax MRNA Option Income Strategy ETF(MRNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MRNY YieldMax MRNA Option Income Strategy ETF

Trading 03-03 14:44:59 EST

19.29

-0.73

-3.65%

High19.63	Low18.45	Vol350.32K
Open19.24	D1 Closing20.02	Amplitude5.89%
Mkt Cap96.55M	Tradable Cap94.62M	Total Shares5.00M
T/O6.62M	T/O Rate7.14%	Tradable Shares4.90M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MRNY","market":"US","secType":"STK","nameCN":"YieldMax MRNA Option Income Strategy ETF","latestPrice":19.29,"timestamp":1772567024420,"preClose":20.02,"halted":0,"volume":350316,"delay":0,"changeRate":-0.036463536463536485,"floatShares":4904974,"shares":5004974,"eps":0,"marketStatus":"Trading","change":-0.73,"latestTime":"03-03 14:44:59 EST","open":19.24,"high":19.63,"low":18.45,"amount":6616189.535652,"amplitude":0.058941,"askPrice":19.4,"askSize":200,"bidPrice":19.24,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1772571600000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":20.02,"sharesOutstanding":5004974,"nav":19.97,"aum":99949330.78,"dividendRate":0.863544,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":19.69,"preClose":20.02,"latestTime":"09:27 EST","volume":13362,"amount":260374.93845000002,"timestamp":1772548060985,"change":-0.33,"changeRate":-0.016484,"amplitude":0.018981},"postHourTrading":{"tag":"盘后","latestPrice":20.1,"preClose":20.02,"latestTime":"19:49 EST","volume":843,"amount":16905.3943,"timestamp":1772498973186,"change":0.08,"changeRate":0.003996,"amplitude":0.003996},"volumeRatio":0.857482,"impliedVol":0.5623,"impliedVolPercentile":0.428},"requestUrl":"/m/hq/s/MRNY","defaultTab":"news","newsList":[{"id":"2616486327","title":"Moderately bullish activity in Moderna with shares down 7.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616486327","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616486327?lang=en_us&edition=fundamental","pubTime":"2026-03-04 00:40","pubTimestamp":1772556041,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Moderna (MRNA), with shares down $3.78 near $49.06. Options volume relatively light with 20k contracts traded and ca...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-down-7-15-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-down-7-15-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4551","MRNY","BK4534","BK4139","BK4585","MRNA","BK4501","BK4532","BK4568","BK4588","MRNX","BK4533"],"gpt_icon":0},{"id":"2616405293","title":"Should You Listen to Billionaires to Buy Moderna Stock in 2026?","url":"https://stock-news.laohu8.com/highlight/detail?id=2616405293","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616405293?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:44","pubTimestamp":1772541850,"startTime":"0","endTime":"0","summary":"A useful rule of thumb is to think of billionaire interest as a prompt to re-underwrite the story. Question: Can Moderna’s respiratory franchise stabilize and grow with flu, can the oncology pipeline provide a 2nd growth leg in a few years, and is the current valuation adequately discounting clinica","market":"sg","thumbnail":"https://resource.tradingkey.com/uploads/20240822/2fbcd158922b425ab15e03d3df2a3df1biotech6.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20240822/2fbcd158922b425ab15e03d3df2a3df1biotech6.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/261639386-listen-billionaires-buy-moderna-stock-mrna-2026-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4139","BK4501","MRNX","BK4551","BK4588","MRNY","MRNA","BK4548","BK4585","BK4532","BK4568","BK4533"],"gpt_icon":0},{"id":"2616346879","title":"MAHA Is Bringing Chaos to Biotech Investment Beyond Just Vaccines -- Heard on the Street -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2616346879","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616346879?lang=en_us&edition=fundamental","pubTime":"2026-03-03 18:30","pubTimestamp":1772533800,"startTime":"0","endTime":"0","summary":"Finding out you're sick is hard enough. Finding out you have a disease shared by less than 1% of the population with no established treatment is something else entirely.Rare disease breaks the traditional math of drug development. Companies can't run a 10,000-patient trial when only a few thousand patients exist worldwide. One way to get those treatments to patients sooner are accelerated approvals: a Food and Drug Administration review process that clears drugs based on early biological signals, instead of waiting years for definitive proof that they improve real-world outcomes.Much of the tension centers on Vinay Prasad, the head of the FDA's Center for Biologics Evaluation and Research . A longtime academic critic of the agency, Prasad built his reputation through books and articles that challenged the pharmaceutical industry -- some of which have specifically argued the accelerated approval process has grown too lenient. With Prasad now installed in a key leadership role, the agenc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4533","BK4581","BK4551","BK4568","BK4532","XBI","MRNX","RGNX","CAPR","BK4563","MRNY","BK4505","BK4548","BK4534","BK4585","REPL","MRNA","LABU","BK4501"],"gpt_icon":0},{"id":"2616988361","title":"Moderna Stock (MRNA): Is It a Buy Now? 7 Questions After the Crash","url":"https://stock-news.laohu8.com/highlight/detail?id=2616988361","media":"InvestorPlace","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616988361?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:28","pubTimestamp":1772486901,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) stock has shed roughly 90% of its value since its 2021 peak. When I wrote about the Moderna stock setup last week, shares…","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"investorplace_stock_picks","url":"https://investorplace.com/2026/03/moderna-stock-mrna-buy-now-march-2026/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://investorplace.com/2026/03/moderna-stock-mrna-buy-now-march-2026/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investorplace_stock_picks","symbols":["BK4139","MRNY","BK4501","BK4548","BK4534","BK4551","BK4588","BK4585","BK4533","BK4568","BK4532","MRNX","MRNA"],"gpt_icon":0},{"id":"2616335009","title":"Correction to FDA Article on Feb. 11 -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2616335009","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616335009?lang=en_us&edition=fundamental","pubTime":"2026-03-03 02:37","pubTimestamp":1772476620,"startTime":"0","endTime":"0","summary":"An HHS spokesman said that no allegations of sexual harassment have been filed against Vinay Prasad, the head of the FDA's vaccine and biologics division. \"Why the FDA Blocked Moderna's New Flu Shot -- WSJ\" published at 9 p.m. ET on Feb 11 and an update at 9:23 p.m. ET incorrectly said that personnel complaints filed against Prasad included allegations of sexual harassment.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4548","BK4532","MRNY","BK4568","BK4588","MRNA","BK4533","BK4551","MRNX","BK4585","BK4534","BK4501"],"gpt_icon":0},{"id":"2614868216","title":"Rothschild & Co Redburn Adjusts Price Target on Moderna to $40 From $36, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2614868216","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614868216?lang=en_us&edition=fundamental","pubTime":"2026-02-28 00:03","pubTimestamp":1772208228,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $40.95, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4551","BK4588","MRNA","MRNX","MRNY","BK4534","BK4568","BK4533","BK4139","BK4548","BK4585","BK4501"],"gpt_icon":0},{"id":"2614854911","title":"Moderna Says Covid-Flu Combination Shot Mcombriax May Be Available in Certain EU Markets for the 2026/2027 Season - Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2614854911","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614854911?lang=en_us&edition=fundamental","pubTime":"2026-02-27 22:26","pubTimestamp":1772202381,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZN2HS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4551","MRNX","BK4585","BK4501","BK4533","BK4534","BK4139","BK4588","BK4532","BK4568","MRNA","BK4548","MRNY"],"gpt_icon":0},{"id":"2614485497","title":"Moderna - Anticipate More Widespread Availability of Mcombriax in EU in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2614485497","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614485497?lang=en_us&edition=fundamental","pubTime":"2026-02-27 22:26","pubTimestamp":1772202381,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZN2HS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRNX","BK4533","MRNY","BK4534","BK4588","BK4139","BK4551","BK4585","MRNA","BK4532","BK4568","BK4548","BK4501"],"gpt_icon":0},{"id":"2614832401","title":"Moderna gets EU regulator nod for combined COVID, flu vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2614832401","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614832401?lang=en_us&edition=fundamental","pubTime":"2026-02-27 19:07","pubTimestamp":1772190462,"startTime":"0","endTime":"0","summary":"Moderna gets EU regulator nod for combined COVID, flu vaccineFeb 27  - Europe's medicines regulator on Friday recommended granting marketing authorisation to mCombriax, making Moderna's MRNA.O messenger RNA vaccine the world's first combined shot for people aged 50 and older against COVID and seasonal influenza in a single dose.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nL6N3ZN0PC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BK4568","BK4588","BK4532","BK4533","BK4585","MRNA","BK4534","BK4501","MRNY","BK4139","BK4551","BK4548"],"gpt_icon":0},{"id":"2614832146","title":"BRIEF-EMA Recommends Granting Marketing Authorisation In EU For mCombriax","url":"https://stock-news.laohu8.com/highlight/detail?id=2614832146","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614832146?lang=en_us&edition=fundamental","pubTime":"2026-02-27 19:04","pubTimestamp":1772190297,"startTime":"0","endTime":"0","summary":"BRIEF-EMA Recommends Granting Marketing Authorisation In EU For mCombriax Feb 27  - EMA: EMA: FIRST COMBINED COVID-19 AND INFLUENZA VACCINE FOR PEOPLE 50 YEARS AND OLDEREMA: RECOMMENDED GRANTING MARKETING AUTHORISATION IN EU FOR MCOMBRIAX FOR PROTECTING PEOPLE AGED 50 YRS & OLDER AGAINST COVID-19, SEASONAL INFLUENZA ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZN18I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","MRNX","BK4585","BK4501","BK4533","BK4534","BK4139","BK4588","BK4532","BK4568","MRNA","BK4548","MRNY"],"gpt_icon":0},{"id":"2614022900","title":"US FDA to offer bonuses to staff for faster drug reviews, source says","url":"https://stock-news.laohu8.com/highlight/detail?id=2614022900","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614022900?lang=en_us&edition=fundamental","pubTime":"2026-02-27 01:49","pubTimestamp":1772128191,"startTime":"0","endTime":"0","summary":"UPDATE 3-US FDA to offer bonuses to staff for faster drug reviews, source says Updates to change sourcingBy Kamal Choudhury and Sneha  S K","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nL4N3ZM21J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","MRNX","BK4548","BK4588","MRNY","BK4533","BK4585","BK4139","BK4551","BK4568","MRNA","BK4534","BK4532"],"gpt_icon":0},{"id":"2614102504","title":"CDC vaccine advisors to consider COVID-19 vaccine injuries, long COVID","url":"https://stock-news.laohu8.com/highlight/detail?id=2614102504","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614102504?lang=en_us&edition=fundamental","pubTime":"2026-02-26 23:32","pubTimestamp":1772119921,"startTime":"0","endTime":"0","summary":"UPDATE 1-CDC vaccine advisors to consider COVID-19 vaccine injuries, long COVIDAdds background in paragraphs 4-7. Feb 26  - The U.S. CDC's vaccine advisory committee will discuss and may vote on recommendations for issues including COVID-19 vaccine injuries and long COVID at its scheduled meeting on March 18 and 19, according to a notice in the Federal Register.The notice was posted on Wednesday.The recommendations of the Advisory Committee on Immunization Practices historically have been used to guide U.S. health insurance coverage, state policies on vaccines needed for schools and how physicians advise parents and patients.The panel was reconstituted last year after U.S. Health Secretary Robert F. Kennedy Jr., a vaccine skeptic, fired all 17 of its members.Kennedy has sought sweeping changes to the national vaccination policy, including dropping broad recommendations for six childhood shots and cutting mRNA-based vaccine research funding.broad recommendations for COVID-19 vaccines. W","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nL1N3ZM0UX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","SG9999003800.SGD","IE00BLSP4452.SGD","LU0208291251.USD","BK4196","SGXZ57979304.SGD","LU0211331839.USD","BK4548","SG9999002224.SGD","BK4504","IE00BKVL7J92.USD","LU0868494617.USD","LU0289739699.SGD","LU0320765489.SGD","LU1571399168.USD","LU1066051498.USD","BK4139","IE00BLSP4239.USD","LU1059921491.USD","LU0225771236.USD","IE000M9KFDE8.USD","BK4550","MRNY","LU1066053197.SGD","IE00B19Z3581.USD","LU1023059063.AUD","BK4551","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU1699723380.USD","MRNX","LU0985481810.HKD","LU0061475181.USD","SG9999001176.SGD","LU1057294990.SGD","LU0122379950.USD","LU0306806265.USD","LU0162691827.USD","LU0225284248.USD","LU0456855351.SGD","LU0006061336.USD","LU0058720904.USD","LU0321505439.SGD","LU0306807586.USD","LU0432979614.USD","BK4568","LU1894683264.USD","BK4501","LU0070302665.USD","BK4599","LU1894683348.USD","LU0072461881.USD","BK4007","BK4585","BK4534","LU0321505868.SGD","BK4581","BK4588","LU1983299246.USD","SG9999001176.USD","BK4532","BK4592","LU1883839398.USD","SG9999013999.USD","SG9999002232.USD","IE0002270589.USD","LU0170899867.USD","SG9999011175.SGD","LU0234572021.USD","BK4533","IE00BSNM7G36.USD"],"gpt_icon":1},{"id":"2614595054","title":"Moderna President Stephen Hoge Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2614595054","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614595054?lang=en_us&edition=fundamental","pubTime":"2026-02-26 05:51","pubTimestamp":1772056310,"startTime":"0","endTime":"0","summary":"Moderna Inc. President Stephen Hoge reported a disposal of Moderna common shares. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moderna Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 25, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL3hwH9H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Moderna President Stephen Hoge Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4588","BK4532","BK4139","BK4501","BK4585","BK4548","BK4568","MRNY","BK4551","MRNX","BK4534","BK4533"],"gpt_icon":1},{"id":"2614305874","title":"Moderna on Track for Highest Close Since November 2024 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2614305874","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614305874?lang=en_us&edition=fundamental","pubTime":"2026-02-26 03:38","pubTimestamp":1772048280,"startTime":"0","endTime":"0","summary":"Moderna, Inc.  is currently at $52.55, up $2.03 or 4.02%. --Would be highest close since Nov. 5, 2024, when it closed at $53.29. --On pace for largest percent increase since Feb. 19, 2026, when it rose 6.65%. --Currently up eight consecutive days; up 31.01% over this period. --Longest winning streak since May 24, 2024, when it rose for 10 straight trading days. --Down 89.15% from its all-time closing high of $484.47 on Aug. 9, 2021. --Up 56.49% from 52 weeks ago , when it closed at $33.58. --Up 135.02% from its 52-week closing low of $22.36 on Nov. 20, 2025","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4533","BK4139","BK4548","BK4588","MRNX","BK4568","BK4551","MRNY","BK4585","BK4501","BK4534","BK4532"],"gpt_icon":1},{"id":"2613730794","title":"BRIEF-Tectonic Therapeutic Appoints François Nader As Chair And Independent Director Of The Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2613730794","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613730794?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:37","pubTimestamp":1771882632,"startTime":"0","endTime":"0","summary":"BRIEF-Tectonic Therapeutic Appoints Franois Nader As Chair And Independent Director Of The BoardFeb 23 (Reuters) - Moderna Inc MRNA.O:TECTONIC THERAPEUTIC APPOINTS FRANOIS NADER, M.D., AS CHAIR AND IN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA7CNF4X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BK4139","BK4533","TECX","BK4548","BK4568","BK4501","BK4588","MRNY","BK4532","BK4551","BK4585","BK4534"],"gpt_icon":1},{"id":"2613737346","title":"Tectonic Therapeutic Appoints FranÇOis Nader, M.d., as Chair and Independent Director of the Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2613737346","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613737346?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:01","pubTimestamp":1771880460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA7CNF4X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4548","MRNY","BK4534","BK4139","MRNA","BK4551","MRNX","TECX","BK4501","BK4568","BK4588","BK4585","BK4533"],"gpt_icon":0},{"id":"2613737313","title":"Tectonic Therapeutic Inc - Terry Mcguire to Resign as Chair of Tectonic's Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2613737313","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613737313?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:01","pubTimestamp":1771880460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA7CNF4X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","BK4588","BK4551","MRNA","BK4532","BK4533","MRNY","MRNX","BK4568","BK4139","BK4501","BK4534","TECX","BK4585"],"gpt_icon":0},{"id":"2613730150","title":"Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2613730150","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613730150?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:01","pubTimestamp":1771880460,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Feb.  23, 2026  (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc.(NASDAQ: TECX) (“Tectonic”), a clinical-stage biotechnology company focused on the discovery and development of therapeu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/23/3243009/0/en/Tectonic-Therapeutic-Appoints-Fran%C3%A7ois-Nader-M-D-as-Chair-and-Independent-Director-of-the-Board.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","MRNX","BK4588","BK4501","BK4532","BK4568","TECX","BK4551","BK4139","BK4548","BK4534","BK4533","MRNY"],"gpt_icon":1},{"id":"2613373997","title":"Moderna Stock Is Trading Higher Today: What's Going On?","url":"https://stock-news.laohu8.com/highlight/detail?id=2613373997","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613373997?lang=en_us&edition=fundamental","pubTime":"2026-02-24 01:50","pubTimestamp":1771869000,"startTime":"0","endTime":"0","summary":"Moderna Inc (NASDAQ:MRNA) shares are trading higher on Monday. Piper Sandler boosted its price target on the stock to $69 from $63 while reiterating an Overweight rating.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/23/Two-Vials-Of-The-Moderna-Vaccine-With-A-.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/23/Two-Vials-Of-The-Moderna-Vaccine-With-A-.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50791273/moderna-stock-is-trading-higher-today-whats-going-on","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50791273/moderna-stock-is-trading-higher-today-whats-going-on","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4568","BK4533","MRNY","BK4551","MRNX","BK4532","BK4585","BK4534","BK4501","BK4548","BK4588","BK4139","MRNA"],"gpt_icon":1},{"id":"2613773872","title":"Moderately bullish activity in Moderna with shares up 5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613773872","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613773872?lang=en_us&edition=fundamental","pubTime":"2026-02-23 23:15","pubTimestamp":1771859713,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Moderna (MRNA), with shares up $2.95, or 5.92%, near $52.82. Options volume roughly in line with average with 21k co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-up-5-92-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-up-5-92-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","BK4501","BK4532","BK4588","BK4139","MRNA","BK4534","BK4548","BK4585","BK4568","MRNY","BK4551","BK4533"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0219},{"period":"1month","weight":0.0593},{"period":"3month","weight":0.4079},{"period":"6month","weight":0.1506},{"period":"1year","weight":-0.3685},{"period":"ytd","weight":0.3619}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund advisor will seek to employ the fund's investment strategy as the fund relates to MRNA regardless of whether there are periods of adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods. The fund is non-diversified.","exchange":"ARCA","name":"YieldMax MRNA Option Income Strategy ETF","nameEN":"YieldMax MRNA Option Income Strategy ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"YieldMax MRNA Option Income Strategy ETF(MRNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest YieldMax MRNA Option Income Strategy ETF(MRNY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"YieldMax MRNA Option Income Strategy ETF,MRNY,YieldMax MRNA Option Income Strategy ETF股票,YieldMax MRNA Option Income Strategy ETF股票老虎,YieldMax MRNA Option Income Strategy ETF股票老虎国际,YieldMax MRNA Option Income Strategy ETF行情,YieldMax MRNA Option Income Strategy ETF股票行情,YieldMax MRNA Option Income Strategy ETF股价,YieldMax MRNA Option Income Strategy ETF股市,YieldMax MRNA Option Income Strategy ETF股票价格,YieldMax MRNA Option Income Strategy ETF股票交易,YieldMax MRNA Option Income Strategy ETF股票购买,YieldMax MRNA Option Income Strategy ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"YieldMax MRNA Option Income Strategy ETF(MRNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest YieldMax MRNA Option Income Strategy ETF(MRNY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}